Cost-Effectiveness Analysis of Umeclidinium Bromide/Vilanterol 62.5/25 MCG Versus Tiotropium/Olodaterol 5/5 MCG in Symptomatic Patients with Chronic Obstructive Pulmonary Disease in Spain
Abstract
Authors
M Driessen J Whalen B Seewoodharry Buguth LA Vallejo-Aparicio I Naya Y Asukai B Alcázar-Navarrete M Miravitlles F Garcia-Rio N Risebrough